Federal Register: July 12, 2002 (Volume 67, Number 134)
Notices               
Page 46363-46366


-----------------------------------------------------------------------

Preliminary Guidance for Notification of Possession of Select Agents; 
Notice


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Preliminary Guidance for Notification of Possession of Select 
Agents

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services.

ACTION: General notice.

-----------------------------------------------------------------------

SUMMARY: The purpose of this Notice is to announce preliminary guidance 
for notification of possession of select agents as mandated in Section 
202(a) of Public Law 107-188 "Public Health Security and Bioterrorism 
Preparedness and Response Act of 2002."

FOR FURTHER INFORMATION CONTACT: John R. Moore, Centers for Disease 
Control and Prevention, Office of Program Planning and Evaluation, 1600 
Clifton Road NE, Mailstop D-23, Atlanta, Georgia 30333. Telephone: 
(404) 639-7070.

SUPPLEMENTARY INFORMATION: On June 12, 2002, President George W. Bush 
signed Public Law 107-188 "Public Health Security and Bioterrorism 
Preparedness and Response Act of 2002." Section 202(a) of the Act 
directs the Secretary of the Department of Health and Human Services, 
within 30 days of enactment, to provide written guidance on how persons 
in possession of biological agents or toxins shall notify the Secretary 
of such possession. To meet this requirement, the Centers for Disease 
Control and Prevention (CDC) has submitted a proposed data collection 
instrument (see draft form below) and guidance document to the Office 
for Management and Budget (OMB) for approval under the Paperwork 
Reduction Act. CDC published a notice in the Federal Register on July 
2, 2002 inviting public comments on the proposed data collection. 
Public comments are due by July 16, 2002. Within two weeks of this 
date, and upon receipt of OMB approval, CDC will publish another notice 
in the Federal Register announcing approval and publication of the data 
collection instrument. The data collection instrument will contain the 
list of select agents currently contained in 42 CFR part 72, appendix 
A.
    Each facility should designate a responsible facility official 
(RFO) to complete this form by September 10, 2002. It is the 
responsibility of the RFO to ensure management oversight of this 
notification requirement. The RFO should be either a safety officer, a 
senior management official of the facility, or both, who has been 
authorized by the facility to complete and submit the notification 
form. The RFO should not be an individual who actually possesses, uses, 
or transfers such agents or toxins. To complete the notification form, 
the RFO will need to inventory its facility and consult with others 
(e.g., principal investigators) as necessary to obtain the information 
required for the notification form. The RFO must review and sign the 
notification form and will be the point of contact if CDC has questions 
concerning the form or other matters related to the Act. Many 
facilities will receive the form via direct mailing, and the form will 
also be published in the Federal Register.
    Further guidance, the approved data collection instrument, and 
location of submission will be announced at a later date.

    Dated: July 10, 2002.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
BILLING CODE 4163-18-P

[[Page 46365]]

[GRAPHIC] [TIFF OMITTED] TN12JY02.013


[[Page 46366]]


[GRAPHIC] [TIFF OMITTED] TN12JY02.014

[FR Doc. 02-17771 Filed 7-11-02; 10:24 am]
BILLING CODE 4163-18-C